Seminars in Hematology
Volume 46, Supplement 2 , Pages S33-S36, January 2009

Recognizing and Treating Secondary Immune Thrombocytopenic Purpura Associated With Lymphoproliferative Disorders

  • Howard A. Liebman

      Affiliations

    • Corresponding Author InformationAddress correspondence to Howard A. Liebman, MD, Norris Cancer Hospital, Room 3466, 1441 Eastlake Ave, Los Angeles, CA 90033

Jane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California-Keck School of Medicine, Los Angeles, CA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Howard A. Liebman, MD, discloses the following: Consultant: Amgen, GSK, Bristol-Myers Squibb; Grant/Research: Amgen, GSK, Bristol-Myers Squibb.

PII: S0037-1963(08)00203-5

doi:10.1053/j.seminhematol.2008.12.004

Seminars in Hematology
Volume 46, Supplement 2 , Pages S33-S36, January 2009

Article Tools